The only peptide guide that gives every compound a transparent Clarity Score for safety & evidence, and keeps FDA-approved drugs and unregulated "research" chemicals in two clearly separated lanes. The real $/mg and the actual science — no hype.
Real prescription drugs (Ozempic, Mounjaro, Egrifta, Vyleesi…). The approved version belongs under clinician supervision — so we point you to licensed telehealth, not a gray-market vial.
Unregulated gray-market chemicals (BPC-157, TB-500, GHK-Cu…) plus a few only in trials. May be impure or mislabeled. We grade them honestly and link the science.
Research use only — no medical, dosing, or efficacy claims. Compounds are unregulated/investigational except where marked FDA-approved; approved drugs are obtained only through licensed telehealth, never a gray-market vial.
Grouped by the areas of research interest women bring to peptides — skin, libido, and metabolism. Education only, not medical advice or a treatment claim; most human evidence is limited. PT-141 is the one here actually FDA-approved (premenopausal HSDD); other uses are investigational.
What the research actually examines for recovery and inflammation — mostly animal/preclinical, not proof it works in people. Research use only; not medical advice. Tap any card for the science and its Clarity Score.
Every compound gets a 0–100 Clarity Score built from public, verifiable inputs — never a paid placement. Higher = more regulated, better human evidence, and real lab documentation. The score is payment-blind — FDA-approved drugs top it because they're the only regulated, human-trial-backed options, the same reason they're the only lane we route to licensed telehealth. That referral is disclosed and never moves a score.
FDA-approved scores highest; investigational in the middle; unapproved "research only" lowest. Linked to FDA.gov / ClinicalTrials.gov.
Strong human trials beat mixed/early data, which beat animal-only/preclinical. Linked to PubMed.
Share of listings publishing a batch Certificate of Analysis from a named third-party lab.
Pick a goal or a lane. Rows stay grouped into FDA-approved, investigational, and research-only, each carrying its Clarity Score, vendor trust tier, and COA status.
| Peptide | Clarity | Vendor | Size | Price | $/mg ▲ | vs avg | Coupon | COA | Verified | Get it |
|---|
⚙️ Seed data (representative listings, June 2026). Load your full 379-listing dataset into LISTINGS. Shop = affiliate (research only); ✅ approved → licensed telehealth; “Verified Partner” = labeled sponsorship (Gold-tier vendors only).
Click any card for the full page: Clarity Score breakdown, plain-English overview, evidence grade, legal status, prices & price history for that compound, and the real science. Not medical advice; no dosing.
No. BPC-157 has no FDA approval for human use and is sold only as a research chemical. The FDA has flagged it; most evidence is from animal studies.
Same molecule in name only. The approved drug is regulated and pharmacy-dispensed; gray-market "research" semaglutide is unregulated and may be impure or mislabeled. The approved version should be used under clinician supervision — which is why we route you to licensed telehealth.
A transparent 0–100: up to 40 for regulatory status, 30 for strength of human evidence, and 30 for the share of listings with a named-lab Certificate of Analysis. The full breakdown is shown on every compound page. Sponsorships never change a score.
A Certificate of Analysis — a batch lab report showing purity and identity. Strongest = batch-specific, from a named third-party lab, with a chromatogram and a matching lot number.
Most research peptides are legal to sell and possess for research purposes in the US, but are not FDA-approved for human use and are labeled "for research only."